Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0267964 (PAA)
 2,561 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Polymer modified calcium phosphate cements made with cement powders of varying tetracalcium phosphate [TTCP] content were prepared using two different molecular weight fractions of poly(acrylic acid) at four different concentrations. The ratio of the precursors (TTCP:DCPA) in the cement powder was found to influence the initial setting which decreased with increasing concentration of TTCP in the powder phase. It was also observed that cements derived from the higher molecular weight containing PAA yielded significantly (P < 0.05) shorter initial setting time (Ti) than cements containing the lower molecular weight, poly(acrylic acid) [GE7 PAA] The effect of the varying the TTCP content in the three different cement types PCPC-A, PCPC-B and PCPC-C showed that the trends of the compressive strength were specific to the concentration and molecular weight of the poly (acrylic acid). A 20% concentration of Glascol-E7 with a cement powder composed of an equimolar ratio of precursors (PCPC-B) resulted in optimal compressive strength within the range investigated. The TTCP content of the cement powder could also be varied to improve the diametral tensile strengths of the cements; the specific effects however, were again governed by both the concentration and molecular weight of the constituent poly (acrylic acid). The influence of TTCP on both the initial setting time and diametral tensile strength was related to the Ca (2+) ion concentration, which determined the rate and amount of cross-linking in the cement.
 ...
PMID:Poly(acrylic acid) modified calcium phosphate cements: the effect of the composition of the cement powder and of the molecular weight and concentration of the polymeric acid. 1752 64

Diphenylarsinic acid [DPAA(V)] was detected in ground water used as drinking water after a poisonous incident in Kamisu, Japan. An approach to define the target molecules of DPAA(V) with a high throughput analysis of proteins from cultured human cells demonstrated down-regulation of glutaminase C (GAC). GAC is a splicing variant of the kidney-type glutaminase (KGA) gene and has the enzyme activity of phosphate-activated glutaminase (PAG). To gain some insights into the mechanism of arsenic intoxication in Kamisu, the effects of various arsenic compounds, including arsenicals that were detected in ground water ([DPAA(V)], phenylarsonic acid [PAA(V)] and bis(diphenylarsine)oxide [BDPAO(III)]) and rice (phenylmethylarsinic acid [PMAA(V)]), were investigated for the expression of GAC and PAG activity. When cultured human HepG2 cells were incubated with arsenicals for 24h, the pentavalent phenylarsenic form of PAA(V) and PMAA(V) as well as DPAA(V) suppressed the expression of GAC protein and PAG activity in a concentration-dependent manner. On the other hand, the trivalent phenylarsenic form of BDPAO(III) had no suppressive effect on GAC and PAG. In addition, trivalent phenylarsenic compounds, such as the glutathione (GSH) conjugate of DPAA(V) [DPA-GS (III)] and triphenylarsine [TPA(III)], and the inorganic arsenics, iAs(V) and iAs(III), and methylated metabolites of inorganic arsenics, dimethylarsinic acid [DMA(V)] and dimethylarsinous acid [DMA(III)], had no suppressive effect on glutaminase. Likewise, methyl substituents of the hydroxyl groups of DPAA(V), PAA(V) and PMAA(V), diphenylmethylarsine oxide [DPMAO(V)] and phenyldimethylarsine oxide [PDMAO(V)], did not have any suppressive effects. These results suggest that pentavalent arsenic compounds with both phenyl groups and hydroxyl groups are effective in the suppression of glutaminase. In addition, the fact that it was only the arsenicals detected in Kamisu that were effective in suppressing glutaminase provides insights into the cause of the arsenic intoxication at Kamisu.
 ...
PMID:Structure-effect relationship in the down-regulation of glutaminase in cultured human cells by phenylarsenic compounds. 1942 35